{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:33:46Z","timestamp":1793716426659,"version":"4.6.1"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>N6-methyladenosine (m6A) modification has emerged as a critical epigenetic mechanism regulating gene expression in diverse physiological and pathological processes, including cancer. Methyltransferase-like 16 (METTL16), a recently identified m6A methyltransferase, has been shown to influence tumor progression through m6A-dependent regulation of key target genes. Accumulating evidence indicates that METTL16 exerts tumor-suppressive or tumor-promoting roles in a context-dependent manner, affecting cell proliferation, apoptosis, autophagy, and chemotherapeutic response across multiple cancer types such as bladder cancer, lung cancer, colorectal cancer, and acute myeloid leukemia. Mechanistically, METTL16 modifies the mRNA stability and translation of oncogenes or tumor suppressors via recognition of m6A sites, and its expression can be regulated by upstream factors including transcription factors and hypoxia-inducible signals. Recent evidence suggests that METTL16 also modulates the tumor microenvironment (TME), potentially affecting immune cell infiltration, immune checkpoint expression, and tumor immune evasion. Collectively, METTL16 emerges as a pivotal epitranscriptomic regulator linking RNA modification, tumor progression, and immune modulation, offering new avenues for precision oncology.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1706971","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T06:22:16Z","timestamp":1763101336000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["METTL16 emerges as a pivotal epitranscriptomic regulator, linking RNA modification, tumor progression, and immune modulation"],"prefix":"10.3389","volume":"16","author":[{"given":"Qiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism","volume":"21","author":"An","year":"2022","journal-title":"Mol Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.773570","article-title":"N6-methyladenosine RNA modification in the tumor immune microenvironment: novel implications for immunotherapy","volume":"12","author":"Guo","year":"2021","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1053\/j.gastro.2022.06.024","article-title":"METTL3 inhibits antitumor immunity by targeting m(6)A-BHLHE41-CXCL1\/CXCR2 axis to promote colorectal cancer","volume":"163","author":"Chen","year":"2022","journal-title":"Gastroenterology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e1681","DOI":"10.1002\/wrna.1681","article-title":"RNA methyltransferase METTL16: Targets and function. Wiley interdisciplinary reviews","volume":"13","author":"Satterwhite","year":"2022","journal-title":"RNA"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22042176","article-title":"METTL16, methyltransferase-like protein 16: current insights into structure and function","volume":"22","author":"Ruszkowska","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/genes13122312","article-title":"The role of the m(6)A RNA methyltransferase METTL16 in gene expression and SAM homeostasis","volume":"13","author":"Mermoud","year":"2022","journal-title":"Genes"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.759020","article-title":"METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma","volume":"10","author":"Lu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-021-00835-2","article-title":"METTL16 exerts an m(6)A-independent function to facilitate translation and tumorigenesis","volume":"24","author":"Su","year":"2022","journal-title":"Nat Cell Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1038\/s41467-023-42025-8","article-title":"Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer","volume":"14","author":"Sun","year":"2023","journal-title":"Nat Commun"},{"key":"B10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13046-023-02844-5","article-title":"The RNA methyltransferase METTL16 enhances cholangiocarcinoma growth through PRDM15-mediated FGFR4 expression","volume":"42","author":"Liu","year":"2023","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"B11","doi-asserted-by":"publisher","first-page":"102377","DOI":"10.1016\/j.redox.2022.102377","article-title":"Ablation of long noncoding RNA MALAT1 activates antioxidant pathway and alleviates sepsis in mice","volume":"54","author":"Chen","year":"2022","journal-title":"Redox Biol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"108495","DOI":"10.1016\/j.isci.2023.108495","article-title":"Hypoxia induces hepatocellular carcinoma metastasis via the HIF-1\u03b1\/METTL16\/lnc-CSMD1-7\/RBFOX2 axis","volume":"26","author":"Wang","year":"2023","journal-title":"iScience"},{"key":"B13","doi-asserted-by":"publisher","first-page":"217698","DOI":"10.1016\/j.canlet.2025.217698","article-title":"RNA methyltransferase METTL16: From molecular mechanisms to therapeutic prospects in cancers","volume":"624","author":"Shi","year":"2025","journal-title":"Cancer Lett"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet (London England)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"112150","DOI":"10.1016\/j.celrep.2023.112150","article-title":"METTL16 promotes translation and lung tumorigenesis by sequestering cytoplasmic eIF4E2","volume":"42","author":"Wang","year":"2023","journal-title":"Cell Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"136093","DOI":"10.1016\/j.jhazmat.2024.136093","article-title":"m(6)A RNA methyltransferase METTL16 induces Cr(VI) carcinogenesis and lung cancer development through glutamine biosynthesis and GLUL expression","volume":"480","author":"Xie","year":"2024","journal-title":"J Hazard Mater"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.95375","article-title":"METTL16 Promotes Stability of SYNPO2L mRNA and leading to Cancer Cell Lung Metastasis by Secretion of COL10A1 and attract the Cancer-Associated Fibroblasts","volume":"20","author":"Wu","year":"2024","journal-title":"Int J Biol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1186\/s12885-025-14729-1","article-title":"METTL16-dependent GPX4 m(6)A modification links ferroptosis to NSCLC TKIs resistance","volume":"25","author":"Zeng","year":"2025","journal-title":"BMC Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12345","article-title":"Tumor-associated macrophages in liver cancer: From mechanisms to therapy","volume":"42","author":"Cheng","year":"2022","journal-title":"Cancer Commun (London England)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13045-024-01526-9","article-title":"METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation","volume":"17","author":"Xue","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13045-024-01599-6","article-title":"METTL16-SENP3-LTF axis confers ferroptosis resistance and facilitates tumorigenesis in hepatocellular carcinoma","volume":"17","author":"Wang","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13008-025-00152-2","article-title":"METTL16\/IGF2BP2 axis enhances Malignant progression and DDP resistance through up-regulating COL4A1 by mediating the m6A methylation modification of LAMA4 in hepatocellular carcinoma","volume":"20","author":"Cao","year":"2025","journal-title":"Cell Division"},{"key":"B23","doi-asserted-by":"publisher","first-page":"101776","DOI":"10.1016\/j.aohep.2025.101776","article-title":"The promoting effect of the POU3F2\/METTL16\/PFKM cascade on glycolysis and tumorigenesis of hepatocellular carcinoma","volume":"30","author":"Chen","year":"2025","journal-title":"Ann Hepatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s11658-022-00342-8","article-title":"METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m(6)A-dependent manner","volume":"27","author":"Dai","year":"2022","journal-title":"Cell Mol Biol Lett"},{"key":"B25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13046-023-02732-y","article-title":"METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression","volume":"42","author":"Wei","year":"2023","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e13590","DOI":"10.1111\/cpr.13590","article-title":"METTL16-mediated N6-methyladenosine modification of Soga1 enables proper chromosome segregation and chromosomal stability in colorectal cancer","volume":"57","author":"Li","year":"2024","journal-title":"Cell Prolif"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1159\/000536152","article-title":"Pathophysiology of acute myeloid leukemia","volume":"147","author":"Wachter","year":"2024","journal-title":"Acta Haematol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.stem.2022.12.006","article-title":"METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism","volume":"30","author":"Han","year":"2023","journal-title":"Cell Stem Cell"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-025-03563-1","article-title":"METTL16-mediated inhibition of MXD4 promotes leukemia through activation of the MYC-MAX axis","author":"Bove","year":"2025","journal-title":"Oncogene"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126532","article-title":"Ovarian cancer immunotherapy and personalized medicine","volume":"22","author":"Morand","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"9952234","DOI":"10.1155\/2023\/9952234","article-title":"METTL16 Inhibits the Malignant Progression of Epithelial Ovarian Cancer through the lncRNA MALAT1\/\u03b2-Catenin Axis","volume":"2023","author":"Li","year":"2023","journal-title":"Anal Cell Pathol (Amsterdam)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"110510","DOI":"10.1016\/j.abb.2025.110510","article-title":"Norcantharidin inhibits the METTL16\/MAT2A pathway to induce apoptosis and suppress tumor progression in ovarian cancer","volume":"771","author":"Zhang","year":"2025","journal-title":"Arch Biochem Biophys"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet (London England)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e70772","DOI":"10.1002\/cam4.70772","article-title":"The oncogenic role of UBXN1 in gastric cancer is attributed to the METTL16-mediated m6A methylation and histone modifications","volume":"14","author":"Shi","year":"2025","journal-title":"Cancer Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16664","article-title":"METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer","volume":"25","author":"Wang","year":"2021","journal-title":"J Cell Mol Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj0486","article-title":"Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis","volume":"373","author":"Del Poggetto","year":"2021","journal-title":"Sci (New York NY)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-022-00429-3","article-title":"METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinoma","volume":"3","author":"Zeng","year":"2022","journal-title":"Nat Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1138238","article-title":"The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway","volume":"13","author":"Xie","year":"2023","journal-title":"Front Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.7150\/jca.85860","article-title":"Suppression of wnt\/\u03b2-catenin signaling in PDAC via METTL16-mediated N6-methyladenosine modification of DVL2","volume":"14","author":"Yu","year":"2023","journal-title":"J Cancer"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2021.0459","article-title":"Breast cancer: presentation, investigation and management","volume":"83","author":"Katsura","year":"2022","journal-title":"Br J Hosp Med (London England: 2005)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40170-024-00351-5","article-title":"METTL16 regulates the mRNA stability of FBXO5 via m6A modification to facilitate the Malignant behavior of breast cancer","volume":"12","author":"Wang","year":"2024","journal-title":"Cancer Metab"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2022.10.065","article-title":"METTL16 epigenetically enhances GPX4 expression via m6A modification to promote breast cancer progression by inhibiting ferroptosis","volume":"638","author":"Ye","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S520329","article-title":"Nanoformulations downregulating METTL16 combined with mRNA tumor vaccines suppress triple-negative breast cancer and prevent metastasis","volume":"20","author":"Wang","year":"2025","journal-title":"Int J Nanomed"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"Razumilava","year":"2014","journal-title":"Lancet (London England)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"189","DOI":"10.7150\/ijbs.97886","article-title":"METTL16 suppresses ferroptosis in cholangiocarcinoma by promoting ATF4 via m(6)A modification","volume":"21","author":"Zhao","year":"2025","journal-title":"Int J Biol Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57080749","article-title":"Bladder cancer: current challenges and future directions","volume":"57","author":"Dobruch","year":"2021","journal-title":"Med (Kaunas Lithuania)"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.86719","article-title":"METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway","volume":"20","author":"Yu","year":"2024","journal-title":"Int J Biol Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.848582","article-title":"Adaptive immune responses and immunity to SARS-coV-2","volume":"13","author":"Primorac","year":"2022","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00460","article-title":"Targeting autophagy in innate immune cells: angel or demon during infection and vaccination","volume":"11","author":"Tao","year":"2020","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e70060","DOI":"10.1111\/jcmm.70060","article-title":"Multifaceted bioinformatic analysis of m6A-related ferroptosis and its link with gene signatures and tumour-infiltrating immune cells in gliomas","volume":"28","author":"Yang","year":"2024","journal-title":"J Cell Mol Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10238-025-01669-0","article-title":"m6A hypermethylation of TCF-1 regulated by METTL16 promotes acute myeloid leukemia","volume":"25","author":"Li","year":"2025","journal-title":"Clin Exp Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.cmet.2025.07.008","article-title":"Tumor-associated Schwann cell remodeling under metabolic stress via lactate sensing orchestrates pancreatic ductal adenocarcinoma development","volume":"37","author":"Liu","year":"2025","journal-title":"Cell Metab"},{"key":"B53","doi-asserted-by":"publisher","first-page":"109924","DOI":"10.1016\/j.clim.2024.109924","article-title":"METTL3\/16-mediated m(6)A modification of ZNNT1 promotes hepatocellular carcinoma progression by activating ZNNT1\/osteopontin\/S100A9 positive feedback loop-mediated crosstalk between macrophages and tumour cells","volume":"261","author":"Wei","year":"2024","journal-title":"Clin Immunol (Orlando Fla)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.02.006","article-title":"Immune checkpoints and the regulation of tolerogenicity in dendritic cells: Implications for autoimmunity and immunotherapy","volume":"18","author":"Funes","year":"2019","journal-title":"Autoimmun Rev"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.18632\/aging.204980","article-title":"m(6)A methyltransferase METTL16 mediates immune evasion of colorectal cancer cells via epigenetically regulating PD-L1 expression","volume":"15","author":"Wang","year":"2023","journal-title":"Aging"},{"key":"B56","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","article-title":"Macrophages and metabolism in the tumor microenvironment","volume":"30","author":"Vitale","year":"2019","journal-title":"Cell Metab"},{"key":"B57","doi-asserted-by":"publisher","first-page":"588","DOI":"10.18632\/aging.206210","article-title":"Pan-cancer analysis of Methyltransferase-like 16 (METTL16) and validated in colorectal cancer","volume":"17","author":"Liu","year":"2025","journal-title":"Aging"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.18632\/aging.104064","article-title":"Clinical and prognostic pan-cancer analysis of m6A RNA methylation regulators in four types of endocrine system tumors","volume":"12","author":"Li","year":"2020","journal-title":"Aging"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12010155","article-title":"Prognostic values of METTL3 and its roles in tumor immune microenvironment in pan-cancer","volume":"12","author":"Guo","year":"2022","journal-title":"J Clin Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1523503","article-title":"Methyltransferase-like 3-mediated RNA N(6)-methyladenosine contributes to immune dysregulation: diagnostic biomarker and therapeutic target","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1706971\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T06:22:17Z","timestamp":1763101337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1706971\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":60,"alternative-id":["10.3389\/fimmu.2025.1706971"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1706971","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"article-number":"1706971"}}